Class information for:
Level 1: RD BIOSCI//PSEUDOMONAS VACCINE//PNEUMONIA CLIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
15012 667 32.9 53%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
792 11459 QUORUM SENSING//PSEUDOMONAS AERUGINOSA//QUORUM QUENCHING

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 RD BIOSCI Address 3 57% 1% 4
2 PSEUDOMONAS VACCINE Author keyword 3 100% 0% 3
3 PNEUMONIA CLIN Address 2 67% 0% 2
4 RECOMBINANT FLAGELLIN Author keyword 2 67% 0% 2
5 OPRF OPRI Author keyword 1 100% 0% 2
6 P AERUGINOSA OUTER MEMBRANE PROTEINS Author keyword 1 100% 0% 2
7 PSEUDOMONAS AERUGINOSA IMMUNOLOGY Author keyword 1 100% 0% 2
8 PSEUDOMONAS INFECTIONS COMPLICATIONS PREVENTION CONTROL PSEUDOMONAS VACCINES ADVERSE EFFECTS THERAPEUTIC USE Author keyword 1 100% 0% 2
9 SNUH Address 1 100% 0% 2
10 MOL EPIDEMIOL ANTIMICROBIALS Address 1 40% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 PSEUDOMONAS VACCINE 3 100% 0% 3 Search PSEUDOMONAS+VACCINE Search PSEUDOMONAS+VACCINE
2 RECOMBINANT FLAGELLIN 2 67% 0% 2 Search RECOMBINANT+FLAGELLIN Search RECOMBINANT+FLAGELLIN
3 OPRF OPRI 1 100% 0% 2 Search OPRF+OPRI Search OPRF+OPRI
4 P AERUGINOSA OUTER MEMBRANE PROTEINS 1 100% 0% 2 Search P+AERUGINOSA+OUTER+MEMBRANE+PROTEINS Search P+AERUGINOSA+OUTER+MEMBRANE+PROTEINS
5 PSEUDOMONAS AERUGINOSA IMMUNOLOGY 1 100% 0% 2 Search PSEUDOMONAS+AERUGINOSA+IMMUNOLOGY Search PSEUDOMONAS+AERUGINOSA+IMMUNOLOGY
6 PSEUDOMONAS INFECTIONS COMPLICATIONS PREVENTION CONTROL PSEUDOMONAS VACCINES ADVERSE EFFECTS THERAPEUTIC USE 1 100% 0% 2 Search PSEUDOMONAS+INFECTIONS+COMPLICATIONS+PREVENTION++CONTROL+PSEUDOMONAS+VACCINES+ADVERSE+EFFECTS+THERAPEUTIC+USE Search PSEUDOMONAS+INFECTIONS+COMPLICATIONS+PREVENTION++CONTROL+PSEUDOMONAS+VACCINES+ADVERSE+EFFECTS+THERAPEUTIC+USE
7 OUTER MEMBRANE PROTEIN F 1 33% 0% 2 Search OUTER+MEMBRANE+PROTEIN+F Search OUTER+MEMBRANE+PROTEIN+F
8 ANTI INFECTIVE MONOCLONAL ANTIBODIES 1 50% 0% 1 Search ANTI+INFECTIVE+MONOCLONAL+ANTIBODIES Search ANTI+INFECTIVE+MONOCLONAL+ANTIBODIES
9 CINC MRNA 1 50% 0% 1 Search CINC+MRNA Search CINC+MRNA
10 CROSS PROTECTIVE EFFICACY 1 50% 0% 1 Search CROSS+PROTECTIVE+EFFICACY Search CROSS+PROTECTIVE+EFFICACY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HETEROLOGOUS IMMUNOTYPE STRAINS 53 85% 4% 28
2 PORIN PREPARATION 49 94% 3% 17
3 AROA DELETION MUTANT 33 100% 2% 13
4 F I VACCINE 20 100% 1% 9
5 LIPOPROTEIN I 19 80% 2% 12
6 PROTECTIVE VACCINE 19 76% 2% 13
7 MOLECULAR WEIGHT POLYSACCHARIDE 17 59% 3% 19
8 CHRONIC PULMONARY INFECTION 15 44% 4% 27
9 MEMBRANE PROTEIN F 14 53% 3% 18
10 O POLYSACCHARIDE TOXIN 13 71% 1% 10

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Vaccines and immunotherapy against Pseudomonas aeruginosa 2008 62 118 57%
Vaccines for Pseudomonas aeruginosa: a long and winding road 2014 4 125 41%
Recent developments for Pseudomonas vaccines 2011 17 194 56%
Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen 2003 24 50 56%
Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients 2010 10 65 57%
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis 2013 1 11 64%
Application of vaccine technology to prevention of Pseudomonas aeruginosa infections 2005 20 108 56%
Pseudomonas vaccination and immunotherapy - An overview 2001 7 55 80%
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis 2015 0 11 64%
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis 2008 5 10 60%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 RD BIOSCI 3 57% 0.6% 4
2 PNEUMONIA CLIN 2 67% 0.3% 2
3 SNUH 1 100% 0.3% 2
4 MOL EPIDEMIOL ANTIMICROBIALS 1 40% 0.3% 2
5 ANTI INFECT DISCOVERY 1 50% 0.1% 1
6 COMMUNICABLE TROP DIS 1 50% 0.1% 1
7 GRIFFITH MED ORAL HLTH 1 50% 0.1% 1
8 MEDROLLINS 1 50% 0.1% 1
9 OSTALB KLINIKUM 1 50% 0.1% 1
10 PROT REFERENCE IMMUNOPATHOL UNIT 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000223827 EXOU//EXOENZYME S//PSEUDOMONAL ELASTASE
2 0.0000218088 PERFUSED LUNGS//BACTERIA STREPTOCOCCUS PNEUMONIAE//ENZYMES XANTHINE OXIDASE
3 0.0000189445 TERTIARY HEALTH INSTITUTION//IGIENE//
4 0.0000182003 RESPIRATORY MUCINS//NON SECRETOR//BRONCHIAL MUCINS
5 0.0000159617 JOURNAL OF CYSTIC FIBROSIS//INHALED TOBRAMYCIN//PULMONARY EXACERBATION
6 0.0000141116 ASIALO GM1 POSITIVE CELL//AZOCASEIN HYDROLYSIS//EXPTL ALLERGY
7 0.0000130243 INFLAMMAT REGENERAT MED//NONA D ARGININE//CRCERT
8 0.0000123724 OE 6710//PYOCIN TYPING//KLIN FOR ERGRP
9 0.0000121015 FLAGELLIN//TLR5//EPITHELIAL PATHOBIOL
10 0.0000103481 ANTILIPID A//ELEBUTE SCORE//ANTIBIOTIC INDUCED ENDOTOXIN RELEASE